0000899243-18-025773.txt : 20181002
0000899243-18-025773.hdr.sgml : 20181002
20181002160816
ACCESSION NUMBER: 0000899243-18-025773
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181001
FILED AS OF DATE: 20181002
DATE AS OF CHANGE: 20181002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRIEL ROBERT F
CENTRAL INDEX KEY: 0001224110
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-05075
FILM NUMBER: 181101320
MAIL ADDRESS:
STREET 1: 940 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERKINELMER INC
CENTRAL INDEX KEY: 0000031791
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 042052042
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: 940 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781 663 5776
MAIL ADDRESS:
STREET 1: 940 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: EG&G INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: EDGERTON GERMESHAUSEN & GRIER INC
DATE OF NAME CHANGE: 19670626
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-01
0
0000031791
PERKINELMER INC
PKI
0001224110
FRIEL ROBERT F
940 WINTER STREET
WALTHAM
MA
02451
1
1
0
0
President and CEO
Common Stock
2018-10-01
4
M
0
150612
33.87
A
723269
D
Common Stock
2018-10-01
4
S
0
104297
96.75
D
618972
D
Common Stock
2018-10-01
4
S
0
46315
97.73
D
572657
D
NQ Stock Option (right to buy)
33.87
2018-10-01
4
M
0
150612
0.00
D
2020-02-05
Common Stock
150612
0
D
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Friel on August 31, 2018.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $96.30 to $97.29. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $97.30 to $98.29. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option became exercisable in three equal annual installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted.
/s/ John L. Healy (POA on file) for Robert F. Friel
2018-10-02